PHENOTYPIC CONSISTENCY IN HYDROXYLATION OF DESMETHYLIMIPRAMINE AND DEBRISOQUINE IN HEALTHY-SUBJECTS AND IN HUMAN-LIVER MICROSOMES

被引:112
作者
SPINA, E [1 ]
BIRGERSSON, C [1 ]
VONBAHR, C [1 ]
ERICSSON, O [1 ]
MELLSTROM, B [1 ]
STEINER, E [1 ]
SJOQVIST, F [1 ]
机构
[1] KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
关键词
D O I
10.1038/clpt.1984.239
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:677 / 682
页数:6
相关论文
共 21 条
[2]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[3]   GENETIC CONROL OF NORTIPTYLINE KINETICS IN MAN - STUDY OF RELATIVES OF PROPOSITI WITH HIGH PLASMA CONCENTRATIONS [J].
ASBERG, M ;
EVANS, DAP ;
SJOQVIST, F .
JOURNAL OF MEDICAL GENETICS, 1971, 8 (02) :129-&
[4]   THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE [J].
BERTILSSON, L ;
ABERGWISTEDT, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :388-390
[5]  
BERTILSSON L, 1981, LANCET, V1, P560
[6]  
BERTILSSON L, 1982, NEW VISTAS DEPRESSIO, P263
[7]  
CRAMMER JL, 1969, PSYCHOPHARMACOLOGIA, V15, P207
[8]   THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171
[9]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[10]  
HAMMER W, 1969, CLIN PHARMACOL THER, V10, P44